A Phase 1/2 interventional study of thyme honey and Triamcinolone Acetonide in Oral Lichen Planus, sponsored by British University In Egypt. Enrolling by invitation at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2025-02-06.
Sponsored by British University In Egypt · Phase 1/2, Interventional, and Treatment
Among 35 studies in Lichen Planus, Oral with a site in Egypt — 5 open to participants now, 7 under way, 2 of them phase 3. Lichen Planus, Oral · Egypt.
Among the 35 studies in Lichen Planus, Oral with a site in Egypt, this one is the 16th largest by planned enrollment of the 23 interventional ones that give a count, is one of 4 that started in 2024, is the only one in phase 1/2, and was the 28th registered.
142 studies on the registry are indexed under Lichen Planus, Oral; 27 are open to participants now.
Browse Lichen Planus, Oral studies →5 of the 35 studies in Lichen Planus, Oral with a site in Egypt are open now. Recruiting first, the newest first:
British University In Egypt · Sites in Egypt
Ages 18+ · Healthy volunteers
Cairo University · Sites in Egypt
October 6 University · Sites in Egypt
Ages 20–75
Alexandria University · Sites in Egypt
Ages 18–65
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 14 Lichen Planus, Oral studies recruiting now, 10 (71%) set no upper age limit and 2 (14%) stop at 75 or younger; 3 take children under 18; 3 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
35 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 5 · Phase 2 3 · Phase 3 3 · Phase 4 8
First in 2013; this study’s year is marked. 4 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 39 across 101 interventional studies indexed under Lichen Planus, Oral.
Median enrollment 39 across the 23 interventional studies, 70 across the 12 observational. Of the 24 that completed or were terminated, 1 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 35 has an industry lead sponsor. The 10 most frequent:
British University In Egypt is the lead sponsor of 70 studies on the registry; 22 are open to participants now.
British University In Egypt has 2 studies filed under Lichen Planus, Oral — fewer than ten, so there is no comparison to draw.
3 of the studies in Lichen Planus, Oral with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07915570British University In EgyptSalivary IL-8 and Serum IL-6 as Biomarkers for Oral Potentially Malignant Disorders in Smokers and Never-Smokers | 2026-12-30 |
| NCT07846891Ain Shams UniversityLow Level Laser Therapy With Injectable Platelet Rich Fibrin in Management of Oral Lichen Planus | 2027-04-20 |
| NCT07910175Alexandria UniversityCurcumin-mediated Photodynamic Therapy Versus Photobiomodulation in the Treatment of Oral Erosive Lichen Planus | 2027-05-15 |
Add all 3 to your calendar (.ics) → With an account.
Among the 35 studies in Lichen Planus, Oral with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
the study aimed to assess the effect of topical application of thyme honey in comparison to 0.1% triamcinolone acetonide oral paste on the relief of pain and clinical improvement in patients with OLP
Inclusion Criteria:• Patients clinically and histopathologically (if required) diagnosed as suffering from OLP.
Exclusion Criteria:• •Patients suffering from any systemic disease.
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Biopsy and archival tissue
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Immunosuppression
A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.
Read whether the line is about a condition or about medicines, and which medicines and doses it means.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Topical application of Thyme Honey
Dietary Supplement: thyme honey
Topical application of Triamcinolone acetonide
Drug: Triamcinolone Acetonide
Topical application on the oral mucosa
Topical application on the oral mucosa
VAS score assessement
Pain intensity
Time frame: 1 month
measurement of salivary level of miRna155
Time frame: 1 month
Started Oct 2024 (actual). Primary completion is estimated for Feb 2025, 4 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
British University In Egypt